Figure 7. The effects of dPrx5 overexpression on aging and resistance to oxidative stress.
(A) Immunoblot analysis of dPrx5 overexpression. Subcellular fractions (upper panel) were prepared as described in Figure 1. Lower panel, samples were prepared from whole flies. Lanes 1, 2, 3 and 4, driver (Tub-GAL4/+) and three different transgene (UAS-dPrx5/+) controls; lanes 5, 6, and 7, three different experimental (UAS-dPrx5/Tub-GAL4) lines. (B) Life spans of flies overexpressing dPrx5 globally at low levels (with Arm-GAL4 driver) and at high levels (with Tub-GAL4 driver). Pooled data of two independent experiments are shown for each line. The median ages were extended in dPrx5/Arm experimental flies by 24.7 ± 3.7% compared with driver and by 13.4 ± 3.9% compared with transgenic controls. With Tub-GAL4 driver, median age was extended by 29.2 ± 7.7% compared with driver and by 30.0 ± 4.6% compared with transgenic controls. (C) Resistance of 30-day-old flies to 2.5 mM paraquat. Approx. 100–150 flies of each group were fed 1% sucrose solution containing 5 mM paraquat. Similar results were obtained in two independent experiments. The median survival time in experimental flies was increased by 52.6% to 60.0% compared with driver control and by 41.5% to 52.3% compared with transgene controls.